Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer

1.7 million cases of breast cancer are diagnosed every year with 522,000 deaths. Molecular classifications of breast cancer have resulted in improved treatments. However, treatments for triple negative breast cancer (TNBC) are lacking. Analysis of molecular targets for TNBC is a priority. One potent...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Roseweir, Antonia K., McCall, Pamela, Scott, Alison, Liew, Benjamin, Lim, Zhi, Mallon, Elizabeth A., Edwards, Joanne
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5514900/
https://ncbi.nlm.nih.gov/pubmed/28415597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16420
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires